Monday, 26 October 2020 »  Login
in
»
I am at

Dr. Reddy's To Conduct Trial For Russian Covid Vaccine In India

DRL today announced that it had received approval from the DCGI to conduct adaptive phase 2/3 human clinical trials for Russia's Sputnik V vaccine in India.
Hyderabad | 17th October 2020
Dr. Reddy's Laboratories Ltd and Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, today announced that they had received approval from the Drug Control General of India (DCGI) to conduct adaptive phase 2/3 human clinical trials for Russia's Sputnik V vaccine in India.

This will be a multi-centre and randomized controlled study, which will include safety and immunogenicity studies.

Earlier, in September 2020, Dr. Reddy's and RDIF had entered a partnership to conduct clinical trials of Sputnik V and distribute it in India. As part of the partnership, RDIF is to supply 100 million doses of the vaccine to Dr. Reddy's upon regulatory approval in India.

G V Prasad, Co-Chairman and Managing Director, Dr. Reddy's Laboratories, said, "This is a significant development that allows us to commence the clinical trial in India, and we are committed to bringing in a safe and efficacious vaccine to combat the pandemic."

On August 11, 2020, Sputnik V, a purported Covid-19 vaccine developed by the Gamaleya National Research Institute of Epidemiology and Microbiology, was registered by the Ministry of Health of Russia, and became the world's first registered vaccine against Covid-19.

Sputnik V is currently undergoing phase 3 clinical trials in Russia, and the proposed number of subjects is 40,000. Additionally, another phase 3 clinical trial of the vaccine commenced in the UAE last week.
filed in:  Health Care, Coronavirus, Dr. Reddy's Labs, Industry & Business
COMMENTS
Be the first to comment on Dr. Reddy's To Conduct Trial For Russian Covid Vaccine In India! Just use the simple form below.
LEAVE A COMMENT
fullhyd.com has 700,000+ monthly visits. Tell Hyderabad what you feel about Dr. Reddy's To Conduct Trial For Russian Covid Vaccine In India!
[no link to your name will appear, overriding global settings]
To preserve integrity, fullhyd.com allows ratings/comments only with a valid email. Your comments will be accepted once you give your email, and will be deleted if the email is not authenticated within 24 hours.
My name:

Dissatisfied with the results? Report a problem or error, or add a listing.
ADVERTISEMENT
SHOUTBOX!
{{todo.name}}
{{todo.date}}
[
]
{{ todo.summary }}... expand »
{{ todo.text }} « collapse
First  |  Prev  |   1   2  3  {{current_page-1}}  {{current_page}}  {{current_page+1}}  {{last_page-2}}  {{last_page-1}}  {{last_page}}   |  Next  |  Last
{{todos[0].name}}

{{todos[0].text}}

ADVERTISEMENT
This page was tagged for
hyderabad October 2020 News
Health Care news
Coronavirus updates
Follow fullhyd.com on
© Copyright 1999-2009 LRR Technologies (Hyderabad), Pvt Ltd. All rights reserved. fullhyd, fullhyderabad, Welcome To The Neighbourhood are trademarks of LRR Technologies (Hyderabad) Pvt Ltd. The textual, graphic, audio and audiovisual material in this site is protected by copyright law. You may not copy, distribute, or use this material except as necessary for your personal, non-commercial use. Any trademarks are the properties of their respective owners. More on Hyderabad, India. Jobs in Hyderabad.